Stephen D. Hall

18.3k citations

217 papers · 14.1k indexed · 2 hit papers · h-index 63

Impact in

Pharmacology top 0.01%
- Pharmacogenetics and Drug Metabolism
- Drug-Induced Hepatotoxicity and Protection
Transplantation top 0.5%
- Renal Transplantation Outcomes and Treatments

Papers in

Pharmacology 107
- Pharmacogenetics and Drug Metabolism 105
- Drug-Induced Hepatotoxicity and Protection 17
- Inflammatory mediators and NSAID effects 15
Oncology 80
- Drug Transport and Resistance Mechanisms 68

Co-authors: Steven Wrighton Mitchell A. Hamman J. Christopher Gorski David R. Jones David Jones Naga Chalasani D. I. Jones Jack Gorski
Journals: Drug Metabolism and Disposition (34 papers)Clinical Pharmacology & Therapeutics (27 papers)Journal of Pharmacology and Experimental Therapeutics (9 papers)Biochemical Pharmacology (6 papers)Hepatology (5 papers)
Partner nations: United States United Kingdom Australia

In The Last Decade

Stephen D. Hall

208 papers receiving 13.7k citations

Hit Papers

align trajectories log scale

The Cytochrome P450 2B6 (CYP2B6) Is the Main Catalyst of Efavirenz Primary and Secondary Metabolism: Implication for HIV/AIDS Therapy and Utility of Efavirenz as a Substrate Marker of CYP2B6 Catalytic Activity 2003 · 502 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2003 Journal of Pharmacology and Experimental Therapeutics
2001 Nature Genetics

Peers

Countries citing papers authored by Stephen D. Hall

Since Specialization

Citations

This map shows the geographic impact of Stephen D. Hall's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen D. Hall with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen D. Hall more than expected).

Fields of papers citing papers by Stephen D. Hall

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephen D. Hall. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen D. Hall. The network helps show where Stephen D. Hall may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Stephen D. Hall, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Stephen D. Hall Line = papers co-authored together Stephen D. Hall links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	A novel physiologically-based pharmacokinetic model to estimate reduced CYP3A4 activity in cancer patients utilizing the neutrophil-to-lymphocyte ratio as an inflammatory marker European Journal of Clinical Pharmacology ·David E. Coutant, Jessica Rehmel, Donna M. Edwards, Stephen D. Hall	2025	0
2	A Combined Modeling Approach to Predict the Effect of Gastric Emptying Delay on the Pharmacokinetics of Small Molecules CPT Pharmacometrics & Systems Pharmacology ·Maria M. Posada, Karen Schneck, Bridget L. Morse, parkyounmi, Lai Tham, Jessica Rehmel, Світлана Скрипник, 康男吉澤, Stephen D. Hall, Gemma L. Dickinson	2025	0
3	Characterising the inconsistency between perceived and actual sleep and its impact upon cognition and mood Scientific Reports ·A. I. Pelekhovych, A. M. Dyer, Alastair D. Smith, Matthew E. Roser, Ashwin Dhanda, Stephen D. Hall	2024	0
4	Heterotropic allosteric modulation of CYP3A4 in vitro by progesterone: Evidence for improvement in prediction of time-dependent inhibition for macrolides Drug Metabolism and Disposition ·parkyounmi, Nan xu, Abrahamsen Hakon Bjorheim, Trent L. Abraham, A. W. Bell, Stephen D. Hall	2024	0
5	Proof-of-Concept Vacuum Microelectronic NOR Gate Fabricated Using Microelectromechanical Systems and Carbon Nanotube Field Emitters Micromachines ·Tasso von Windheim, Kristin H. Gilchrist, Charles B. Parker, Stephen D. Hall, James Carlson, David L. Stokes, 张秀莲, C. T. Hess, Leif Scheick, B.G. Rax, Brian R. Stoner, Jeffrey T. Glass, Jason J. Amsden	2023	3
6	Abemaciclib Does Not Have a Clinically Meaningful Effect on Pharmacokinetics of CYP1A2, CYP2C9, CYP2D6, and CYP3A4 Substrates in Patients with Cancer Drug Metabolism and Disposition ·P. Kellie Turner, Stephen D. Hall, Sonya C. Chapman, Jessica Rehmel, Jane Royalty, Yingying Guo, Palaniappan Kulanthaivel	2020	17
7	Ballast Water Flushing of Multiple Tanks on Board Sea-Going Bulk Carriers ANU Open Research (Australian National University) ·Захарова Л. В., Stephen D. Hall	2015	0
8	Prediction of In Vivo Clearance and Associated Variability of CYP2C19 Substrates by Genotypes in Populations Utilizing a Pharmacogenetics-Based Mechanistic Model Drug Metabolism and Disposition ·宣古崎, Fritz Hebeisen, Stephen D. Hall, Yingying Guo	2015	19
9	Identification of the Effect of Multiple Polymorphisms on the Pharmacokinetics of Simvastatin and Simvastatin Acid Using a Population-Modeling Approach Clinical Pharmacology & Therapeutics ·Nikolaos Tsamandouras, Gemma L. Dickinson, Yingying Guo, Stephen D. Hall, Amin Rostami‐Hodjegan, Aleksandra Galetin, Leon Aarons	2014	60
10	The Effects on Metabolic Clearance when Administering a Potent CYP3A Autoinducer with the Prototypic CYP3A Inhibitor, Ketoconazole Drug Metabolism and Disposition ·Gözdem Dittel, Brian A. Willis, Francisco Bruno Forte Rocha, Stephen L. Lowe, Stuart Friedrich, Amparo de la Peña, Wei Zhang, Thomas J. Brown, Stephen D. Wise, Stephen D. Hall	2012	1
11	Prediction of CYP3A-Mediated Drug-Drug Interactions Using Human Hepatocytes Suspended in Human Plasma Drug Metabolism and Disposition ·Jialin Mao, Michael A. Mohutsky, John Harrelson, Steven Wrighton, Stephen D. Hall	2011	45
12	GABA(A) alpha-1 subunit mediated desynchronization of elevated low frequency oscillations alleviates specific dysfunction in stroke – A case report Clinical Neurophysiology ·Stephen D. Hall, Naoki Yamawaki, Nazarette Koulou, R.P. Clauss, Gavin L. Woodhall, Ian M. Stanford	2010	59
13	Hydroxyitraconazole, Formed During Intestinal First-Pass Metabolism of Itraconazole, Controls the Time Course of Hepatic CYP3A Inhibition and the Bioavailability of Itraconazole in Rats Drug Metabolism and Disposition ·Sara K. Quinney, Raymond E. Galinsky, Jane Buckley, Yong Chen, Mitchell A. Hamman, Stephen D. Hall, Robert E. Kimura	2008	25
14	Association Between Nonalcoholic Hepatic Steatosis and Hepatic Cytochrome P-450 3A Activity Clinical Gastroenterology and Hepatology ·Dhanashri Kolwankar, Raj Vuppalanchi, Brian Ethell, David R. Jones, Steven Wrighton, Stephen D. Hall, Naga Chalasani	2007	68
15	Airflow and droplet spreading around oxygen masks: A simulation model for infection control research American Journal of Infection Control ·Margaret Ip, Julian W. Tang, David S.C. Hui, Lindsey Bunn, Matthew T.V. Chan, Gavin M. Joynt, Albert So, Stephen D. Hall, Paul K.S. Chan, Joseph J.�Y. Sung	2007	44
16	A general linear model for MEG beamformer imaging NeuroImage ·Matthew J. Brookes, 文雄栗林, Stephen D. Hall, Paul L. Furlong, Gareth R. Barnes, Arjan Hillebrand, Krish D. Singh, Ian E. Holliday, Susan Francis, Peter G. Morris	2004	38
17	The effects of an oral contraceptive containing ethinyloestradiol and norgestrel on CYP3A activity British Journal of Clinical Pharmacology ·P.A. Podyacheva, John T. Callaghan, J. Christopher Gorski, Juan Maya, Mariana Albuquerque Zan, Steven Wrighton, Stephen D. Hall	2002	54
18	Determination of cytochrome P450 3A4/5 activity in vivo with dextromethorphan N-demethylation* Clinical Pharmacology & Therapeutics ·David R. Jones, J. Christopher Gorski, Sally Abo El-seoud, Edward O’Mara, Stephen D. Hall	1996	58
19	Determination of the epimeric composition of ibuprofenyl-CoA Analytical Biochemistry ·Timothy S. Tracy, Stephen D. Hall	1991	16
20	Relationship between Lipophilicity and Tubular Reabsorption for a Series of 5‐Alkyl‐5‐ethylbarbituric Acids in the Isolated Perfused Rat Kidney Preparation Journal of Pharmaceutical Sciences ·Joachim M. Mayer, Stephen D. Hall, Malcolm Rowland	1988	18

About Stephen D. Hall

Stephen D. Hall is a scholar working on Pharmacology, Oncology, Nuclear Energy and Engineering, Biochemistry and Pediatrics, Perinatology and Child Health, having authored 217 papers that have together received 14.1k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (105 papers), Drug Transport and Resistance Mechanisms (68 papers), Pharmacological Effects and Toxicity Studies (23 papers), Analytical Chemistry and Chromatography (18 papers), Drug-Induced Hepatotoxicity and Protection (17 papers), Neural dynamics and brain function (16 papers), Inflammatory mediators and NSAID effects (15 papers) and Eicosanoids and Hypertension Pharmacology (13 papers). The work is most often cited by research in Pharmacology (6.4k citations), Transplantation (677 citations), Oncology (4.4k citations), Pediatrics, Perinatology and Child Health (2.2k citations) and Virology (428 citations). Stephen D. Hall has collaborated with scholars based in United States, United Kingdom and Australia. Frequent co-authors include Steven Wrighton, Mitchell A. Hamman, J. Christopher Gorski, David R. Jones, David Jones, Naga Chalasani, D. I. Jones, Jack Gorski, Kenneth E. Thummel and Mark VandenBranden. Their work appears in journals such as Drug Metabolism and Disposition, Clinical Pharmacology & Therapeutics, Journal of Pharmacology and Experimental Therapeutics, Biochemical Pharmacology and Hepatology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact